Edwards Lifesciences (EW) Shares Outstanding (Diluted Average) (2009 - 2026)

Edwards Lifesciences has reported Shares Outstanding (Diluted Average) for 16 years, with the latest figure at $580.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 1.21% year-over-year to $580.7 million; the trailing twelve-month figure through Mar 2026 stood at $580.7 million (down 1.21% YoY), and the FY2025 full-year result was $585.8 million, down 2.25% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $580.7 million, down from $585.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $629.4 million in Q1 2022, with the low at $580.7 million in Q1 2026.
• Average Shares Outstanding (Diluted Average) over 5 years is $604.8 million, with a median of $604.3 million recorded in 2024.
• Year-over-year, Shares Outstanding (Diluted Average) declined 0.3% in 2022 and declined 2.94% in 2023.
• Tracing EW's Shares Outstanding (Diluted Average) over 5 years: stood at $624.2 million in 2022, then dropped by 2.37% to $609.4 million in 2023, then fell by 1.66% to $599.3 million in 2024, then declined by 2.25% to $585.8 million in 2025, then decreased by 0.87% to $580.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $580.7 million (Q1 2026), $585.8 million (Q4 2025), and $585.7 million (Q3 2025), per Business Quant data.

Peer Comparison